Amiodarone Infusion Rate Recommendations
The recommended maintenance infusion rate for amiodarone is 0.5 mg/min, and 0.7 mg/min exceeds the standard recommended rate. 1, 2
Standard Amiodarone IV Administration Protocol
According to the FDA drug label and major cardiology guidelines, amiodarone IV administration follows a three-stage approach:
- Initial loading dose: 150 mg over 10 minutes
- Early maintenance infusion: 1 mg/min for 6 hours
- Later maintenance infusion: 0.5 mg/min 1, 2
The total dose over 24 hours should not exceed 2.2 g 2.
Rate Increase Considerations
When considering increasing the amiodarone infusion rate:
- Maximum recommended maintenance rate: 0.5 mg/min according to FDA labeling and ACC/AHA/ESC guidelines 1, 2
- Safety concerns: Higher rates increase risk of:
- Hypotension
- Bradycardia
- Heart block
- Phlebitis (especially with concentrations >2 mg/mL) 2
Clinical Situations Where Rate Adjustments May Be Considered
In breakthrough episodes of ventricular fibrillation or hemodynamically unstable ventricular tachycardia:
- Use 150 mg supplemental infusions over 10 minutes rather than increasing the maintenance rate 1
Important Safety Considerations
- Monitoring: Continuous ECG monitoring is essential during amiodarone administration 2
- Administration route: Use a central venous catheter for concentrations >2 mg/mL 1
- Concentration limits: Do not exceed 2 mg/mL for peripheral infusions lasting >1 hour 1
- Contraindications: Severe sinus node dysfunction, marked bradycardia, second/third-degree AV block without pacemaker 2
Practical Recommendations
If rate control is inadequate at 0.5 mg/min:
- First option: Administer a supplemental 150 mg bolus over 10 minutes rather than increasing the maintenance rate 1
- Second option: Consider adding another agent if appropriate
- If rate increase is absolutely necessary: Close monitoring for hypotension, bradycardia and heart block is essential 2
Conclusion
Based on the most current guidelines and FDA labeling, 0.7 mg/min exceeds the standard recommended maintenance infusion rate of 0.5 mg/min. While some studies have used higher rates in specific circumstances, the standard recommendation should be followed to minimize risk of adverse effects.